Moderna says its COVID-19 vaccine appears to be 94.5% effective

It can be stored at a much warmer temperature than Pfizer's vaccine too.
Publish date:

Moderna has become the latest company to announce success in the efficacy of its COVID-19 vaccine.

The biotech firm announced Monday that the early results of its vaccine show it is 94.5% effective in preventing the virus, and expects to have 20 million doses of the two-dose vaccine available by the end of the year and 500 million to 1 billion available in 2021.

The study has yet to be peer reviewed, is still subject to FDA approval, and it's not yet known how long the immunity lasts, but nonetheless represents another sign of hope that humanity could return to a semblance of normality later in 2021.

Moderna's study involved 30,000 adult participants, some of whom were given the vaccine and others a placebo.

Moderna found that 95 people had contracted the virus two weeks after the second dose was administered, of which 90 had received the placebo. What's more, all 11 people who had severe COVID-19 were in the placebo group.

Of those who got the virus, 12 were Hispanic or Latino, four were Black or African American, three were Asian American, and one is multiracial.

It comes a week after Pfizer announced a vaccine that has 90% efficacy, but one of the significant benefits of the Moderna vaccine is that it can be stored at up to -4F, compared to Pfizer's -94F – and can last up to 12 hours at room temperature.

Unlike Pfizer's vaccine, the development of the Moderna vaccine was part-funded by the federal Operation Warp Speed, launched by the Trump Administration for the research, manufacture, and distribute a COVID-19 vaccine as soon as possible.

Follow Bring Me The News on News Break

Next Up


Drug overdose deaths up 31% in the first half of 2020

Overdose deaths started to increase sharply in March, which coincides with the state-ordered lockdown for the COVID-19 pandemic.

los ocampos

Video: Vehicle crashes into St. Paul restaurant

The fire department is on scene addressing a gas leak.

covid-19, coronavirus

Latest county infection rates are sky-high throughout Minnesota

Kandiyohi County is one of the hardest hit counties in the state.

Jenna Fish

Family's warning after teen's tragic death from CO poisoning at Thanksgiving

A 17-year-old girl from Delano died after Thanksgiving due to carbon monoxide poisoning.


More than $12K donated to MN gym owner who refused to close

The small business is located in town in Wabasha County.

radio station, microphone

MPR, The Current launch new weekly segment called 'The Warming House'

The program will feature feel-good entertainment amid the pandemic.

coronavirus, COVID-19 test

Dec. 3 COVID-19 update: 92 deaths marks MN's 2nd-highest total

The deaths continue to surge amid the worst of the pandemic so far.

mohamed amin bayle idd booking photo

2 men charged in connection to fatal shooting at Bloomington apartment complex

Shakur Freed Muhammed, 22, of Hopkins, was fatally shot Monday morning.

Screen Shot 2020-12-03 at 9.11.36 AM

Hewing Hotel finds workaround to shutdown, delivering 7-course meal to rooms

The hotel will convert guest rooms into dining rooms for three-hour reservations.

Jan and Chris Kruse

'Dateline' episode will explore Minnesota woman's unsolved murder

Jan Pigman-Kruse was fatally shot in her bed in 2015. Her husband was acquitted in the case.


flu shot, vaccine

Pfizer seeks permission for emergency use of COVID-19 vaccine

The drug maker says its vaccine is 95% effective and ready to be deployed.

flu shot, vaccine

MDH reveals likely plan for when COVID-19 vaccine is available in MN

The department says those most at risk will be prioritized first.

coronavirus, covid-19

Pfizer, BioNTech SE announce their COVID-19 vaccine is 90% effective

The companies are applying for FDA approval later in November.


Phase III COVID-19 vaccine trial halted after 'potentially unexplained illness'

Dr. Michael Osterholm said he'd be surprised if the illness was caused by the potential vaccine.

flu shot, vaccine

Mayo specialist: 'Doubly important' to get a flu shot this year

Anyone over the age of 6 months should receive a flu vaccine.

coronavirus, covid-19

HealthPartners to join Oxford University COVID-19 vaccine trial

The Minnesota health system will enroll 1,500 people in the trial.

coronavirus, COVID-19

U of M researchers working to develop vaccine for future coronavirus strains

Other vaccines currently in development would target COVID-19, but not necessarily other variants.

coronavirus, covid-19

Minneapolis Fed president says national lockdown needed to control COVID-19

Neel Kashkari put forward his two cents in a New York Times op-ed Friday.